Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MedMira Inc MMIRF


Primary Symbol: V.MIR

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely... see more

TSXV:MIR - Post Discussion

MedMira Inc > UPDATES CHINESE COVID19 CHINA VRIANT SPREADING
View:
Post by august202013 on Jan 02, 2023 7:30pm

UPDATES CHINESE COVID19 CHINA VRIANT SPREADING

Latest updates

COVID19 VARIANT FROM CHINA ALREADY IN SOUTH EAST ASIA 

MEDMIRA MUST ACT NOW TO PENETRATE INYO SOUTH IN ASIA WITH THEIR VYRA !

AGAIN IF UNABLE PENETRATE THERE ARE SOME MEDMIRA LONG TERM SHAREHOLDERS WHO MIGHT BE ABLE TO ASSIST MM KNOW THEM. PREVIOUSLY HAVE ALREADY VOLUNTEERED BUT NO RESPONSE.

MM PROBABLY CAN REACH THE CONTACT NOW IF WANT TO PROCEED.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities